Multi-editor CRISPR platform from microbial dark matter using metagenomics + ML; lead ABO-101 for primary hyperoxaluria type 1 (FDA IND accepted); liver and CNS pipeline incl ALS
No detailed funding rounds available.
Total known funding:
